WO2002020049A3 - Eiav chimeric vaccine and diagnostic - Google Patents
Eiav chimeric vaccine and diagnosticInfo
- Publication number
- WO2002020049A3 WO2002020049A3 PCT/US2001/027599 US0127599W WO0220049A3 WO 2002020049 A3 WO2002020049 A3 WO 2002020049A3 US 0127599 W US0127599 W US 0127599W WO 0220049 A3 WO0220049 A3 WO 0220049A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- eiav
- diagnostic
- vaccine
- chimeric vaccine
- vaccinated
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000713730 Equine infectious anemia virus Species 0.000 abstract 2
- 241000713666 Lentivirus Species 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 2
- 241000283086 Equidae Species 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- AIDS & HIV (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002524532A JP2004522697A (en) | 2000-09-09 | 2001-09-06 | EIAV chimeric vaccines and diagnostics |
AU8710301A AU8710301A (en) | 2000-09-09 | 2001-09-06 | Eiav chimeric vaccine and diagnostic |
EP01966602A EP1345622A2 (en) | 2000-09-09 | 2001-09-06 | Eiav chimeric vaccine and diagnostic |
BR0113745-0A BR0113745A (en) | 2000-09-09 | 2001-09-06 | Vaccine, diagnostic test and methods for immunizing mammals and preparing a vaccine |
AU2001287103A AU2001287103B2 (en) | 2000-09-09 | 2001-09-06 | EIAV chimeric vaccine and diagnostic |
AU2007201936A AU2007201936A1 (en) | 2000-09-09 | 2007-05-01 | EIAV Chimeric Vaccine and Diagnostic |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65902900A | 2000-09-09 | 2000-09-09 | |
US09/659,029 | 2000-09-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002020049A2 WO2002020049A2 (en) | 2002-03-14 |
WO2002020049A3 true WO2002020049A3 (en) | 2003-07-03 |
Family
ID=24643739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/027599 WO2002020049A2 (en) | 2000-09-09 | 2001-09-06 | Eiav chimeric vaccine and diagnostic |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1345622A2 (en) |
JP (1) | JP2004522697A (en) |
AU (2) | AU2001287103B2 (en) |
BR (1) | BR0113745A (en) |
WO (1) | WO2002020049A2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996005292A1 (en) * | 1994-08-15 | 1996-02-22 | Connaught Laboratories Limited | Antigenically-marked non-infectious retrovirus-like particles |
WO1998039463A2 (en) * | 1997-03-06 | 1998-09-11 | Ueberla Klaus | Lentivirus based vector and vector system |
WO1999032646A1 (en) * | 1997-12-22 | 1999-07-01 | Oxford Biomedica (Uk) Limited | Equine infectious anaemia virus (eiav) based |
WO2000063387A1 (en) * | 1999-04-21 | 2000-10-26 | National Center For Aids Prevention And Control | The full gene sequence of the donkey leukocyte vaccine strain of the equine infectious anemia virus and their application |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3873690A (en) * | 1974-01-23 | 1975-03-25 | Iii James H Rand | Equine infectious anemia vaccine |
US5614404A (en) * | 1988-06-10 | 1997-03-25 | Theriod Biologics, Incorporated | Self-assembled, defective, non-self-propagating lentivirus particles |
EP0981636B1 (en) * | 1997-05-13 | 2005-03-23 | University Of North Carolina At Chapel Hill | Lentivirus-based gene transfer vectors |
-
2001
- 2001-09-06 EP EP01966602A patent/EP1345622A2/en not_active Withdrawn
- 2001-09-06 AU AU2001287103A patent/AU2001287103B2/en not_active Ceased
- 2001-09-06 WO PCT/US2001/027599 patent/WO2002020049A2/en active Application Filing
- 2001-09-06 JP JP2002524532A patent/JP2004522697A/en not_active Withdrawn
- 2001-09-06 AU AU8710301A patent/AU8710301A/en active Pending
- 2001-09-06 BR BR0113745-0A patent/BR0113745A/en not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996005292A1 (en) * | 1994-08-15 | 1996-02-22 | Connaught Laboratories Limited | Antigenically-marked non-infectious retrovirus-like particles |
WO1998039463A2 (en) * | 1997-03-06 | 1998-09-11 | Ueberla Klaus | Lentivirus based vector and vector system |
WO1999032646A1 (en) * | 1997-12-22 | 1999-07-01 | Oxford Biomedica (Uk) Limited | Equine infectious anaemia virus (eiav) based |
WO2000063387A1 (en) * | 1999-04-21 | 2000-10-26 | National Center For Aids Prevention And Control | The full gene sequence of the donkey leukocyte vaccine strain of the equine infectious anemia virus and their application |
EP1174507A1 (en) * | 1999-04-21 | 2002-01-23 | National Center for Aids prevention and control | The full gene sequence of the donkey leukocyte vaccine strain of the equine infectious anemia virus and their application |
Non-Patent Citations (2)
Title |
---|
LU J ET AL: "DIFFERENTIAL TEST ON SERUM ANTIBODY FROM EIA HORSES WITH THAT FROM ATTENUATED EIA VACCINE IMMUNIZED HORSES", SCIENTIA AGRICULTURA SINICA, vol. 22, no. 6, 1989, pages 69 - 75, XP001148407, ISSN: 0578-1752 * |
VIGNE R ET AL: "PRECURSOR POLY PEPTIDES TO STRUCTURAL PROTEINS OF VISNA VIRUS", JOURNAL OF VIROLOGY, vol. 42, no. 3, 1982, pages 1046 - 1056, XP008014040, ISSN: 0022-538X * |
Also Published As
Publication number | Publication date |
---|---|
BR0113745A (en) | 2004-03-02 |
AU2001287103B2 (en) | 2007-02-01 |
JP2004522697A (en) | 2004-07-29 |
AU8710301A (en) | 2002-03-22 |
EP1345622A2 (en) | 2003-09-24 |
WO2002020049A2 (en) | 2002-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200701176B (en) | Vaccines against aids comprising CMV/R-nucleic acid constructs | |
WO2004060308A3 (en) | Thiosemicarbazones as anti-virals and immunopotentiators | |
ATE451119T1 (en) | SUBUNITY VACCINE AGAINST RESPIRATORY SYNZYTIAL VIRUS | |
WO2007064742A3 (en) | Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof | |
DE60226911D1 (en) | Development of a vaccine for the prevention of filovirus infections in primates | |
NO20055857L (en) | Materials and Methods for Immunization against FIV Infection | |
EE9900343A (en) | Synthetic Polynucleotide, Immune Response Method, Immunogenic Composition, Anti-HIV Immune Response Induction Method, Antigen-Inducing Cell Indication, and Pharmaceutical Composition | |
EP4219566A3 (en) | Recombinant rsv antigens | |
MX9203458A (en) | IMMUNOGENIC SEGMENTS CONTAINING CHEMICAL GLYCOPROTEINS FROM HUMAN RESPIRATORY SYNCITIAL VIRUS GLYCOPROTEINS. | |
HUT69803A (en) | Porcine reproductive respiratory syndrome vaccine and diagnostic | |
HK1043943A1 (en) | Streptococcus pneumoniae proteins and vaccines | |
AP2002002685A0 (en) | Use of flavivirus for the expression of protein epitpoes and development of new live attenuated vaccine virus to immune against flavivirus and other infectious agents | |
WO2002087494A3 (en) | Novel vaccine | |
WO2002045742A8 (en) | Lipoteichoic acid immunogenic compositions and methods of making and using thereof | |
CA2399172A1 (en) | Cold-adapted equine influenza viruses | |
WO2002072802A3 (en) | Live attenuated strains of prrs virus | |
EA200700496A1 (en) | INACTIVATED POLYOMYELITE VACCINE, RECEIVED FROM STRAIN OF SEIBIN VIRUS OF POLIOMYELITIS | |
WO2002004002A3 (en) | Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals | |
WO2002009752A3 (en) | Immunological adjuvant compounds | |
MXPA03009763A (en) | Foot and mouth disease virus vaccine. | |
WO2001004280A3 (en) | Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat | |
WO2002009749A3 (en) | Respiratory syncytial virus vaccine | |
WO2002020049A3 (en) | Eiav chimeric vaccine and diagnostic | |
DE69738641D1 (en) | LIVING VACCINE AGAINST HELIOBACTER PYLORI | |
WO2001074386A3 (en) | Cold-adapted equine influenza viruses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001966602 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002524532 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001287103 Country of ref document: AU |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001966602 Country of ref document: EP |